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Profiling of Haemophilus influenzae strain R2866
with carbohydrate-based covalent probes†
Camille Metier,a Jennifer Dow,b Hayley Wootton,a Steven Lynham,c Brendan Wrenb
and Gerd K. Wagner *d
We demonstrate the application of four covalent probes based on anomerically pure D-galactosamine
and D-glucosamine scaffolds for the profiling of Haemophilus influenzae strain R2866. The probes have
been used successfully for the labelling of target proteins not only in cell lysates, but also in intact cells.
Differences in the labelling patterns between lysates and intact cells indicate that the probes can pene-
trate into the periplasm, but not the cytoplasm of H. influenzae. Analysis of selected target proteins by
LC-MS/MS suggests predominant labelling of nucleotide-binding proteins, including several known anti-
bacterial drug targets. Our protocols will aid the identification of molecular determinants of bacterial
pathogenicity in Haemophilus influenzae and other bacterial pathogens.
Introduction
The profiling of pathogenic bacteria with chemical probes is a
powerful strategy to uncover molecular determinants of bac-
terial pathogenicity, virulence, and antimicrobial resistance.1–3
Typically, such probes contain a reactive moiety for the for-
mation of a covalent linkage, enabling the irreversible label-
ling of target proteins. Both targeted4 and target-agnostic5
approaches have been explored for such applications, with
natural products being a particularly common scaffold for
probe development.6–8 For target deconvolution in complex
systems, such covalent probes can be conveniently interfaced
with bioanalytical methods such as mass spectrometry and gel
electrophoresis.9
Carbohydrates are an attractive scaffold for the develop-
ment of covalent probes for the profiling of bacterial patho-
gens, both from a chemistry and microbiology perspective.
Even a simple monosaccharide allows the facile installation of
both an electrophilic warhead for covalent labelling, and a
reporter group for detection (Fig. 1). Moreover, most sugars are
readily water soluble, which is a considerable advantage for
applications in biological media. Sugars such as D-glucose and
α-lactose are preferred bacterial carbon sources10 and, together
with other sugars, serve as building blocks for complex glycans
of the bacterial cell wall (e.g., lipopolysaccharide, peptidogly-
can).11 Carbohydrates and carbohydrate-recognising proteins
are often directly involved in multiple aspects of bacterial
pathogenicity,12 including adhesion,12 immune evasion,12
virulence,13,14 and biofilm formation.15 Carbohydrate-based
covalent probes are therefore excellent tools for the profiling of
bacterial cells and the labelling of proteins involved in bac-
terial pathogenicity.
Several examples for the labelling of bacterial proteins with
covalent probes based on a carbohydrate, or carbohydrate-like,
scaffold have previously been reported. Usually, these probes
are designed to specifically recognise a single target protein.
Thus, a glucosamine-based probe has been used successfully
to capture the β-N-acetylhexosaminidase NagZ, which is
involved in the induction of resistance to β-lactams, from non-
purified lysates of P. aeruginosa.16 More recently, Titz et al.
have described a galactose-derived probe for the labelling and
in vitro imaging of the lectin LecA, a virulence factor and
biofilm building block from P. aeruginosa.17 A probe based on
Fig. 1 General design of carbohydrate-based covalent probes.
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the cyclitol mimic cyclophellitol aziridine has been used for
the labelling of the retaining GH29 α-L-fucosidase from
Bacteroides thetaiotaomicron, both in recombinant form and in
lysates from an E. coli culture overexpressing the target
enzyme.18
We have recently used a covalent probe based on a
D-glucosamine scaffold for the profiling of K. pneumoniae
lysates.19 In the present study, we have extended our general
approach to a different scaffold based on D-galactosamine, and
another bacterial pathogen, Haemophilus influenzae.
H. influenzae is a Gram-negative coccobacillus responsible for
life-threatening invasive diseases such as pneumonia and
meningitis.20 A cytoplasmic glycosylation system of
H. influenzae has been reported, and many carbohydrate
binding proteins21 involved in the pathogenicity of the bacter-
ium, including lectins22 and glycosyltranferases,23 have been
identified. H. influenzae strain R2866 is an unusually virulent
non-typeable strain first isolated from the blood of children
with meningitis infection.24,25 Although lacking a capsular
polysaccharide structure, H. influenzae R2866 displays elevated
serum resistance and a virulence level approaching that of
encapsulated type b H. influenzae,24 and these traits have been
closely related to the presence of a terminal galactoside
epitope of the outer-membrane lipooligosaccharide (LOS)
structure.24,26
In this study, we sought to assess the capacity of different
carbohydrate-based probes to simultaneously label multiple
target proteins in H. influenzae R2866. We reasoned that such
a protocol may aid not only the profiling of this strain, but
also the identification of antibacterial targets. We were particu-
larly interested in the application of our probes not only with
cell lysates, but also, for the first time, with intact cells. Our
results show that probes derived from D-glucosamine and
D-galactosamine are indeed suitable for such applications.
Moreover, notable differences between the profiles obtained
from lysates and intact cells suggest, that our protocols can
also provide additional information about the localisation of
target proteins within the bacterial cell.
Results and discussion
Chemical synthesis of carbohydrate-based probes
The two anomers 7-α and 7-β of D-galactosamine-based target
molecule 7 were synthesised in six steps from D-galactosamine
1 (Scheme 1A). We reasoned that O-acetylated probes were
more likely than free sugars to penetrate the bacterial mem-
brane and were therefore more suited for labelling experi-
ments with intact bacterial cells.
First, O-selective acetylation of 1 was achieved in three steps
via the strategy of Wulffen et al.27 1 was converted into the
corresponding imine 2 by reaction with p-anisaldehyde, fol-
lowed by quantitative O-acetylation of 2. Imine hydrolysis of 3
under acidic conditions gave O-acetylated D-galactosamine 4.
Next, the electrophilic warhead was installed in position 2 by
reaction of 4 with chloroacetyl chloride, to give the 2-(2-chloro-
acetamido) derivative 5. Finally, the reporter group was
attached at the anomeric position via a short linker. 5 was
reacted with propynol ethoxylate under Fischer glycosylation
conditions to give glycoside 6 as a mixture of both anomers,
which were separated by normal phase chromatography. Each
anomer was reacted separately in a Cu-catalysed 1,3-dipolar
cycloaddition with azide 9,28 introducing a dansyl fluorophore,
to give the D-galactosamine-based target molecules 7-α and 7-
β. The successful cycloaddition was evidenced by 1H NMR
(CDCl3), which showed the diagnostic triazole signal at 7.61
and 7.67 ppm for 7-α and 7-β respectively. The corresponding
D-glucosamine derivatives 8-α and 8-β as well as their deacety-
lated parent sugars 11-α and 11-β (Scheme 1B) were prepared
as previously reported.19
Assignment of anomers
The identity of the individual anomers was unambiguously
assigned for both series by 1D and 2D NMR analysis. The weak
orbital overlap between H1 and H2 protons in the α-anomer is
associated with a small coupling constant 3J1,2, as observed for
7-α (3J1,2 3.5 Hz). A large coupling constant 3J1,2 on the other
hand, is characteristic of the β-anomer (7-β: 3J1,2 8.5 Hz). These
assignments are further supported by ROESY spectra of each
anomer. The 1,3-diaxial orientation of the H1, H3, and H5
protons in the β-anomer leads to diagnostic H1–H3 and H1–H5
crosspeaks, as observed in the ROESY spectrum of 7-β (ESI
Fig. S1†). In contrast, these crosspeaks are absent from the
ROESY spectrum of 7-α (ESI Fig. S2†) due to the equatorial
orientation of H1 in the α-anomer. Assignments for 8-α and 8-
β were made as previously reported.19
Labelling of a bacterial glycosyltransferase in cell lysates
In order to assess the capability of our probes to label a carbo-
hydrate-recognising protein, we carried out labelling experi-
ments with the retaining α-1,4-galactosyltransferase LgtC from
Neisseria meningitidis, which catalyses the transfer of
D-galactose from a UDP α-D-galactose donor to a lactose accep-
tor.29 LgtC was overexpressed in BL21* E. coli cells. Cells were
lysed, and cell lysates were incubated for 30 min at 30 °C with
the D-glucosamine derivatives 8-α and 8-β, or the fluorophore
control 10. To assess the potential effect of the acetate protect-
ing groups on labelling, we also included the deacetylated
sugars 11-α and 11-β (Scheme 1B) in these experiments.
Samples were separated on a 12% SDS-page gel under denatur-
ing conditions and analysed by in-gel fluorescence emission
and Coomassie staining (Fig. 2).
In the case of the acetylated probes, both anomers 8-α and
8-β produced a fluorescently labelled band of LgtC, although
this band was weaker for the β-anomer. Interestingly, in the
case of the deacetylated probes, strong fluorescent labelling
was only observed with the α-anomer 11-α. As expected, no lab-
elling was observed with the fluorophore control 10. These
results demonstrate that 8-α and 8-β are capable of labelling
target proteins in complex biological media. They also suggest
that the presence of the acetate protecting groups, in conjunc-
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tion with the anomeric configuration, may affect labelling
efficacy and/or target recognition.
Profiling of H. influenzae R2866 lysates
Next, we set out to assess the suitability of the pure anomers 7-
α, 7-β, 8-α and 8-β for the profiling of H. influenzae R2866.
First, we investigated all four probes for the labelling of target
proteins in cell lysates. To identify optimum growth conditions
for labelling experiments, growth kinetics of R2866 were estab-
lished over 24 hours. We observed a doubling time of 60 min,
with the stationary phase reached at 8–9 hours, and a
maximum OD590 of 1.9 (ESI Fig. S3†). For labelling experi-
ments, cell cultures of H. influenzae R2866 were grown in Brain
Heart infusion (BHI) broth until mid-logarithmic phase was
reached (OD590 0.9; 5 hours). The cells were then harvested by
centrifugation and pellets equivalent to 1 mL of cell culture
were lysed with BugBuster protein extraction reagent. Cell
debris was removed by centrifugation, and the supernatant
was incubated with probes 7-α, 7-β, 8-α or 8-β (0.5 mM) or con-
trols. Controls included a DMSO-only sample, as well as the
dansyl fluorophore 10 (0.5 mM), which is lacking both the
sugar scaffold and the electrophilic warhead (Scheme 1C).
Lysate fractions treated with either probe or control were separ-
ated on a 4–12% SDS-page gel, and analysed by in-gel fluo-
rescence emission and Coomassie staining (Fig. 3).
For all four probes, a defined labelling pattern of proteins
over a wide MW range (∼20–100 kDa) was observed (Fig. 3).
This pattern was absent from the control lanes, with the excep-
tion of a strong band of an autofluorescent protein at
∼28 kDa. There was no significant difference in the labelling
profile between the four different probes. This suggests that
the configuration at position 4 (D-gluco vs. D-gala series) or
position 1 (α vs. β anomer) of the sugar scaffold has only a
minor influence on the target profile. The similar labelling
intensity observed for both anomers, both for 7 and 8, is remi-
niscent of the observation in the labelling experiments with
LgtC, and suggest that the acetate groups remain intact under
these conditions.
Scheme 1 (A) Synthesis of D-galactosamine-based probes 7-α and 7-β. Reagents and conditions: (i) p-Anisaldehyde (1 equiv.), NaOH (1 M), 0 °C; (ii)
acetic anhydride (8 equiv.), pyridine (excess), rt, 16 hours; (iii) acetone, HCl (4 M, 1.2 equiv.), 56 °C, 5 min; (iv) chloroacetyl chloride (3 equiv.) TEA (2
equiv.), DCM, rt, 2 hours; (v) propynol ethoxylate (3 equiv.), BF3 × Et2O (4 equiv.), DCM, 40 °C, 8 hours; (vi) dansyl azide 9 (1 equiv.), CuSO4–5H2O (1
equiv.), sodium ascorbate (1.5 equiv.), DIPEA (3 equiv.), THF : water (10 : 1), rt, 3 hours. (B) D-Glucosamine-based probes 8-α, 8-β, 11-α and 11-β.19 (C)
Control compounds 9 and 10 (see ESI† for synthesis).
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Particularly strong fluorescence was observed for a band at
∼50 kDa (Fig. 3, asterisk). The corresponding band in the
Coomassie stain was relatively weak, indicating that this is a
low-abundance protein. In contrast, several high-abundance
proteins that give strong Coomassie bands were not, or only
weakly, labelled by the fluorescent probes. Taken together, this
suggests that protein abundance is not the determining factor
for labelling by these probes.
Under these experimental conditions, labelling efficiency
was dependent on probe concentration, as expected (Fig. 4).
The resolution of the labelling pattern is significantly reduced
at probe concentrations lower than 250 μM, although individ-
ual bands with strong fluorescent labelling, such as the low-
abundance protein at 50 kDa, can still be detected at probe
concentrations as low as 50 μM (Fig. 4).
Protein labelling in intact H. influenzae R2866 cells
Following the successful profiling of H. influenzae R2866
lysates, we next tested the suitability of probes 7-α, 7-β, 8-α
and 8-β for the labelling of proteins in intact cells. First, we
carried out bacterial growth assays to ensure that the probes
did not compromise cell viability. No effect on bacterial
growth was observed, suggesting that the probes were suited
for profiling experiments with intact cells (ESI Fig. S4†). Next,
we assessed the capacity of the probes to penetrate the bac-
terial membrane. Cells were grown as described and harvested
by centrifugation. Pellets equivalent to 4 mL of cell cultures
were incubated for 2 hours with 7-α, 7-β, 8-α, 8-β, 10 (fluoro-
phore control, Scheme 1), or DMSO (control). After incubation,
unbound probe was removed by consecutive washes (5%
DMSO in PBS) and centrifugation.
After four washes, no fluorescence was detected in the
supernatant (Fig. 5A). Cell pellets that had been incubated
with probes or fluorophore control remained fluorescent,
while cells incubated with DMSO control showed no fluo-
rescence (Fig. 5B). Cell pellets were collected, lysed, and centri-
fuged. The fluorescence of samples that had been incubated
with probes or fluorophore control persisted in the soluble
fraction after cell lysis (Fig. 5C). These results provided a first
indication that all four probes as well as the fluorophore
control can penetrate into the periplasm and/or cytoplasm of
H. influenzae R2866, and hence that the carbohydrate scaffold
Fig. 2 Labelling of recombinant LgtC with 8-α, 8-β, 11-α and 11-β in
E. coli lysates. General conditions: E. coli cells overexpressing LgtC were
lysed (8 h after IPTC induction) by mixing with BugBuster (100 μL for
100 mg of cell pellet, prepared from 10× stock in HEPES buffer) for
30 min at rt. Following centrifugation, the supernatant was divided into
fractions (9 μL) and incubated with stock solutions (1 μL, 5 mM stock in
DMSO) of 8-α, 8-β, 11-α, 11-β or 10 (fluorophore control) for 1 hour at
30 °C. Loading buffer (2.5 μL) was added to each fraction (10 μL).
Samples were incubated at 50 °C for 10 min and loaded onto a 12%
SDS-page gel. The gel was run with MES running buffer at 160 V for
70 min. Protein bands were detected by fluorescence scanning (left) and
Coomassie staining (right).
Fig. 3 Protein labelling with 7-α, 7-β, 8-α and 8-β in H. influenzae
R2866 cell lysates. General conditions: Cells were grown to OD590 0.9
and lysed by mixing with BugBuster (100 μL, ×1 in PBS, for pellet of 4 mL
of cell culture) for 30 min at rt. Following centrifugation, the supernatant
was divided into fractions (9 μL) and incubated with stock solutions
(1 μL, 5 mM stock in DMSO) of 7-α, 7-β, 8-α, 8-β or 10 (fluorophore
control), or DMSO (1 μL, control) for 1 hour at 30 °C. Loading buffer
(2.5 μL) was added to each fraction (10 μL) and loaded onto a 4–12%
SDS-page gel. The gel was run with MES running buffer at 150 V for
70 min. Protein bands were detected by fluorescence scanning (left) and
Coomassie staining (right). The asterisk denotes the low-abundance
protein at 50 kDa labelled by all four probes (see text).
Fig. 4 Effect of probe concentration on the labelling of H. influenzae
R2866 lysates. General conditions as in Fig. 2. Following cell lysis and
centrifugation, the supernatant was divided into fractions (9 μL) and
incubated with stock solutions (1 μL, 5–0.25 mM stock in DMSO) of 7-α
or 10 (control). Protein bands were detected by fluorescence scanning
(left) and Coomassie staining (right). The asterisk denotes the low-abun-
dance protein at 50 kDa labelled by all four probes (see text).
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in 7 and 8 does not impede penetration of the bacterial
membrane.
To further confirm these results, we next investigated the
labelling of intracellular proteins by our probes. Cell lysates
were separated on a 4–12% SDS-page gel and analysed by fluo-
rescence emission and Coomassie staining (Fig. 6). As for the
application of 7 and 8 with cell lysates, a defined labelling
pattern of proteins over a wide MW range (∼13–100 kDa) was
observed for all four probes under these conditions (Fig. 6).
Labelling efficiency was again concentration-dependent (ESI,
Fig. S5†). While the only strong fluorescent band in the control
lanes for DMSO and 10 resulted from the unknown autofluor-
escent protein at ∼28 kDa, a number of additional bands were
observed for control 9. Most likely, these are due to protein lab-
elling by the reactive azide group in 9 (Scheme 1C).
While the labelling pattern of intact cells was very similar
for all four probes, there were notable differences between this
profile (Fig. 6), and the profile obtained from labelling of cell
lysates (Fig. 3). Most significantly, the strongly fluorescent
band at ∼50 kDa that had been observed with the cell lysate
labelling protocol was absent from the intact cell experiment.
To further investigate these intriguing differences, we decided
to compare both labelling protocols side by side in a single
experiment.
Direct comparison of H. influenzae R2866 profiling in intact
cells and cell lysates
A bacterial culture was grown as described, half of which was
used for protein labelling through cells (1 mM of 7-α/β and 8-
α/β, 2 hours) while the other half was lysed and subsequently
incubated with the glucosamine-based probe (0.5 mM,
1 hour). The lysate samples from both experiments were
loaded on a single 4–12% SDS-page gel to enable the direct
comparison of the labelling profiles (Fig. 7).
The labelling profiles obtained with the two different proto-
cols showed a number of differences, confirming our obser-
vations in the previous, separate experiments. Several targets
were labelled exclusively with one protocol, but not the other
(Fig. 7). The most notable difference was the presence of a
strongly fluorescent band at ∼50 kDa, which is detected only
by labelling of cell lysates, but not of intact cells.
A possible explanation for these differences is, that the
probes penetrate the outer bacterial membrane and reach the
periplasm of H. influenzae R2866, but cannot cross the inner
membrane to reach the cytoplasmic space. The probes would
therefore be able to only capture periplasmic proteins in the
labelling experiment with intact cells, but both periplasmic
and cytoplasmic proteins in the protocol with cell lysates. We
therefore hypothesised that the proteins labelled exclusively in
Fig. 5 Protein labelling in intact H. influenzae R2866 cells. Cell pellets
were incubated for 2 hours with 7-α, 7-β, 8-α, 8-β or 10 (fluorophore
control) at 1 mM, or DMSO (control). (A) Supernatant after repeated
washes (5% DMSO in PBS) of pellets that had been incubated with probe
(results shown for 7-α) or DMSO (control); (B) cell pellets that had been
incubated with probe, DMSO (control) or 10 (fluorophore control) after
four washes (5% DMSO in PBS); (C) soluble fraction of the pellets from
(B) after lysis and centrifugation. Fluorescence emission at 365 nm.
Fig. 6 Protein labelling with 7-α, 7-β, 8-α and 8-β in intact
H. influenzae R2866 cells. General conditions: Cells were grown to
OD590 0.9. Cell pellets were suspended in PBS (900 μL) and incubated
with stock solutions (100 μL, 10 mM in DMSO) of probes 7-α, 7-β, 8-α,
8-β or fluorophore controls 9 or 10, or with DMSO (control), for two
hours at 30 °C. Cells were washed (4×, 5% DMSO in PBS), lysed with
BugBuster (100 μL, ×1 in PBS), and shaken for 30 min at rt, and centri-
fuged. Loading buffer (2.5 μL) was added to the clear supernatant (10 μL)
and loaded onto a 4–12% SDS-page gel. Gels were run with MES
running buffer at 150 V for 70 min. Protein bands were detected by
fluorescence scanning (left) and Coomassie staining (right).
Fig. 7 Direct comparison of protein labelling with 7-α, 7-β, 8-α and 8-β
in intact cells and cell lysates from H. influenzae R2866. See Fig. 3 and 5
for general conditions. The asterisk denotes the low-abundance protein
at 50 kDa which is detected, by all four probes, in cell lysates only.
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the bacterial cell lysate experiment may be located in the bac-
terial cytoplasm.
Analysis of selected target proteins by LC-MS/MS
To further assess this hypothesis, we sought to establish the
identity of selected target proteins. Selected bands were
excised from the requisite gel and analysed by LC-MS/MS fol-
lowing in-gel reduction, alkylation and digestion with trypsin.
The resulting peptide fragments were matched against the
current H. influenzae taxonomy in the Uniprot database (ESI†).
This analysis suggests two probable assignments for the
band at ∼50 kDa that is detected selectively by labelling of cell
lysates: FtsZ (45 kDa), a cytoplasmic GTPase that is central for
the bacterial cell division machinery;30 and Elongation Factor
Tu (43 kDa), another cytoplasmic GTPase involved in polypep-
tide chain elongation in protein biosynthesis.31 Interestingly,
both proteins have been identified as attractive targets for
small-molecule antibacterial drug discovery.30,31 These results
are in keeping with our hypothesis that the protein labelled
exclusively with the cell lysate protocol is located in the
cytoplasm.
High-probability assignments for other target proteins (ESI,
Fig. S6†) include many nucleotide-binding proteins, including
the chaperone protein DnaK (68 kDa), periplasmic NAD
nucleotidase (66 kDa), and DNA-directed RNA polymerase
subunit beta, a nucleotidyl-transferase (157 kD). DnaK is an
outer membrane protein known to mediate sulfatide reco-
gnition32 and a biofilm protein in non-typeable Haemophilus
Influenzae.33 These results suggest that probes 7 and 8 may act
as nucleotide mimics, possibly because of the combination of
a simple sugar with the dansyl fluorophore, which may be
reminiscent of a nucleobase.
Conclusion
We have synthesised both anomers of a D-galactosamine-based
fluorescent probe in six steps from D-galactosamine with an
overall yield of 22%. These probes, alongside their
D-glucosamine congeners, were used successfully for the label-
ling of multiple target proteins in both cell lysates and intact
cells of Haemophilus influenzae R2866. In both the
D-galactosamine and D-glucosamine series, the labelling pro-
files and intensities for the fully acetylated probes were practi-
cally identical for both anomers. This is consistent with obser-
vations for the labelling of the recombinant galactosyltransfer-
ase LgtC, where labelling was comparable between both
anomers of the fully acetylated D-glucosamine-based probes 8-
α and 8-β, but significantly different between both anomers of
the corresponding free sugars 11-α and 11-β. This suggests
that the fully acetylated probes are also the active species in
the labelling experiments with Haemophilus lysates and intact
cells, and that the acetate groups remain intact under these
conditions.
While the labelling profile observed with all four probes
was practically identical, notable differences were observed
between profiles from the lysate and intact cell experiments.
The exclusive labelling of a cytoplasmic protein in lysate
samples, but not intact cells, suggests that these probes can
indeed penetrate the outer, if probably not the inner, bacterial
membrane.
The cell envelope of Gram-negative bacteria represents a
formidable permeability barrier, and considerable efforts are
being made to identify small molecules that can cross this
barrier.34–36 The ability of these probes to penetrate the bac-
terial membrane, as reported in this study, is therefore of con-
siderable interest. Initial target identification experiments
suggest that these probes preferentially label nucleotide-
binding proteins. This is consistent with the labelling of LgtC,
where labelling may occur at the sugar-nucleotide donor
binding site. Interestingly, potential target proteins include
several known antibacterial drug targets. These probes there-
fore represent exciting new tool compounds to study the role
of such nucleotide-binding proteins for bacterial pathogenicity




General. All chemical reagents were obtained commercially
and used as received, with the exception of propynol ethoxylate
which was distilled prior to use. Compounds 8-α, 8-β, 11-α
and 11-β were prepared as previously reported.19 Normal
phase chromatography was performed on silica gel (particle
size 40–63 μm). Thin layer chromatography (TLC) was per-
formed on precoated aluminium plates (Silica Gel 60 F254,
Merck). Compounds were visualised by staining with p-anisal-
dehyde and/or exposure to UV light (365 nm). All compounds
were characterized by 1H-NMR, 13C-NMR, and MS. 1H-NMR
spectra were recorded at 298 K on a Bruker Ascend™ 400
spectrometer at 400 MHz. 13C-NMR spectra were recorded at
298 K on either a Bruker Ascend™ 400 spectrometer at
100 MHz, or a Bruker Ascend™ 600 spectrometer at 150 MHz.
Chemical shifts (δ) are reported in ppm and referenced to
residual solvent peaks. Peak assignments were made with the
aid of 2D NMR spectra (COSY, HSQC, HMBC and DEPT).
HRMS spectra were recorded at the EPSRC National Mass
Spectrometry Service Centre, Swansea. LC-MS analysis was per-
formed on an Agilent Technologies 1260 Infinity II LC system,
equipped with a ZORBAX Eclipse XDB-C8 column (4.6 ×
150 mm, 5 μm), and coupled to an Advion expressionL CMS
mass spectrometer. Mobile phase: 0.1% formic acid in water/
methanol; flow rate: 1 mL min−1; detection wavelength: 210/
254 nm. All solvents used for reverse phase chromatography
were HPLC grade.
Compound 2. Galactosamine hydrochloride 1 (9.25 mmol)
was dissolved in aq. NaOH (1 M, 9.3 mL) at 0 °C.
p-Anisaldehyde (1 equiv.) was added dropwise, and the
mixture was shaken vigorously. Upon formation of a white
solid, the reaction was placed in the freezer (−20 °C) for 1 h to
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complete precipitation. The solid was collected by filtration,
washed dropwise with ice-cold H2O (10 mL) and ice-cold
EtOH : Et2O (1 : 1, 10 mL), and dried under vacuum to give 2 as
a white powder in 56% yield. 1H NMR (400 MHz, DMSO-d6) δ
3.09 (dd, 3J 9.5 Hz, 3J 7.7 Hz, 1H, H-2 sugar), 3.46 (t, 3J 6.2 Hz,
1H, H-5 sugar), 3.50–3.62 (m, 3H, H-3, H-6 sugar), 3.67 (t, 3J
3.5 Hz, 1H, H-4 sugar), 3.80 (s, 3H, H-methoxy), 4.39 (d, 3J 4.4
Hz, 1H, H-hydroxyl), 4.50 (d, 3J 7.0 Hz, 1H, H-hydroxyl),
4.58–4.64 (m, 2H, H-1 anomeric, H-hydroxyl), 6.42 (d, 3J 6.3
Hz, 1H, H-hydroxyl), 6.98 (d, 3J 8.8 Hz, 2H), 7.67 (d, 3J 8.8 Hz,
2H), 8.13 (s, 1H, H-imine). 13C NMR (100 MHz, DMSO-d6) δ
55.3 (C-methoxy), 60.7 (C-6 sugar), 67.2 (C-4 sugar), 71.6 (C-3
sugar), 74.5 (C-2 sugar), 75.1 (C-5 sugar), 96.1 (C-1 sugar),
113.9 (×2), 129.2, 129.5 (×2), 161.0, 161.2 (C-imine).
Compound 3. 2 (3.20 mmol) was dissolved in pyridine
(10 mL) at 0 °C. Acetic anhydride (8 equiv.) was added drop-
wise, the reaction was warmed to room temperature and
stirred overnight (16 h). The reaction mixture was poured into
ice (50 mL) under stirring. The precipitate was collected by fil-
tration, washed with ice-cold H2O (200 mL) and ice-cold EtOH
(2 mL), and dried under vacuum, to give 3 as a white powder
in 99% yield. 1H NMR (400 MHz, DMSO-d6) δ 1.82, 1.97, 2.00,
2.12 (4s, 12H, CH3CO), 3.52 (dd,
3JH2–H3 10.3 Hz,
3JH2–H1 8.2
Hz, 1H, H-2 sugar), 3.79 (s, 3H, H-methoxy), 4.04–4.09 (m, 2H,
H-6 sugar), 4.46 (t, 3JH5–H6 6.5 Hz, 1H, H-5 sugar), 5.27 (d,
3JH4–H3 3.3 Hz, 1H, H-4 sugar), 5.35 (dd,
3JH3–H2 10.4 Hz,
3JH3–H4 3.4 Hz, 1H, H-3 sugar), 5.98 (d,
3JH1–H2 8.2 Hz, 1H, H-1
anomeric), 6.99 (d, 3J 8.8 Hz, 2H), 7.67 (d, 3J 8.8 Hz, 2H), 8.31
(s, 1H, H-imine). 13C NMR (100 MHz, DMSO-d6) δ 20.3, 20.4,
20.5, 20.5, (4C, CH3CO), 55.4 (C-methoxy), 61.4 (C-6 sugar),
66.0 (C-4 sugar), 68.4 (C-2 sugar), 70.9 (C-5 sugar), 70.9 (C-3
sugar), 92.8 (C-1 sugar), 114.2, 128.3, 129.9, 161.8, 164.7
(C-imine), 168.6, 169.2, 169.9, 170.0 (4C, CH3CO).
Compound 4. 3 (2.70 mmol) was dissolved in acetone
(11 mL) and the solution was heated to reflux. Aq. HCl (4 M,
1.2 equiv.) was added dropwise under stirring. After about
5 min, a white precipitate formed. Heating was continued for a
further 2 min. The precipitate was collected by filtration and
washed with ice-cold acetone (50 mL), to give 4 as a white
powder in 88% yield. 1H NMR (400 MHz, DMSO-d6) δ 1.99,
2.00, 2.12, 2.16 (4s, 12H, CH3CO), 3.39 (dd,
3JH2–H1 8.2 Hz,
3JH2–H3 6.2 Hz, 1H, H-2 sugar), 4.98–4.09 (m, 2H, H-6 sugar),
4.29 (t, 3J 6.3 Hz, 1H, H-5 sugar), 5.24–5.32 (m, 2H, H-3, H-4
sugar), 5.89 (d, 3JH1–H2 8.7 Hz, 1H, H-1 anomeric), 8.71 (s, 3H,
NH). 13C NMR (100 MHz, DMSO-d6) δ 20.3, 20.5, 20.7, 20.8
(4C, CH3CO), 49.4 (C-2 sugar), 61.2 (C-6 sugar), 68.8, 65.8 (C-3,
C-4 sugar), 71.1 (C-5 sugar), 90.3 (C-1 sugar), 168.6, 169.3,
169.9, 169.9 (4C, CH3CO).
Compound 5. To a suspension of 4 (0.4 mmol) in DCM
(2 mL), triethylamine (2 equiv.) was added. The reaction
mixture was stirred at room temperature until all solid was dis-
solved (approx. 2 min). The solution was cooled to 0 °C, and
chloroacetyl chloride (3 equiv.) was added dropwise. The reac-
tion mixture was stirred at 0 °C for 10 min, and at room temp-
erature until TLC (8 : 1 EtOAc : hexane) showed full conversion
(1 h). The reaction was quenched by addition of saturated aq.
NaHCO3 solution (5 mL). DCM (10 mL) was added and the two
layers were separated. The aqueous phase was extracted with
DCM (3 × 10 mL). The organic layers were combined and dried
over MgSO4. After filtration the mixture was concentrated
under vacuum. The residue was purified by normal phase
column chromatography (EtOAc/hexane) to afford the title
compound as an off-white crystalline product in 85% yield. 1H
NMR (400 MHz, CDCl3) δ 2.02, 2.05, 2.13, 2.17 (4s, 12H,
CH3CO), 4.00 (s, 2H, H-7), 4.06 (td,
3J 6.5 Hz, 3J 1.0 Hz, 1H,
H-5), 4.09–4.20 (m, 2H, H-6), 4.38 (dt, 3J2–3 11.3 Hz,
3J2-NH 9.0
Hz, 1H, H-2), 5.24 (dd, 3J3–2 11.3 Hz,
3J3.4 3.3 Hz, 1H, H-3),
5.38–5.42 (m, 1H, H-4), 5.82 (d, 3J1–2 8.8 Hz, 1H, H-1), 6.48 (d,
3J 9.2 Hz, 1H, NH). 13C NMR (100 MHz, CDCl3): δ 20.7, 20.7,
20.8, 21.0 (4C, CH3CO), 42.5 (C-7), 50.5 (C-2), 61.5 (C-6), 66.6
(C-4), 69.9 (C-3), 71.9 (C-5), 92.5 (C-1), 166.9 (C-8), 169.5, 170.2,
170.6, 170.6 (CH3CO). LC-MS (m/z) 446.3 [M + Na
+] (calculated
446.2).
Compounds 6-α and 6-β. 5 (1.06 mmol) was dissolved in
DCM (3 mL), and the solution was cooled to 0 °C.
Borontrifluoride diethyletherate (4 equiv.) and propynol ethox-
ylate (3 equiv.) were added dropwise, and the reaction was
stirred at 40 °C for 8 h. The reaction mixture was diluted with
DCM (7 mL) and washed with saturated aq. K2CO3 (2 × 10 mL)
and brine (2 × 10 mL). The organic layer was separated, dried
over MgSO4, and concentrated under vacuum. The crude
residue was purified by normal phase column chromatography
(0–20% acetone in toluene) to give two products. Each product
was further purified by reverse phase column chromatography
(10–30% EtOAc in hexane) to give the title compounds as pale
yellow oils in 34% (6-α) and 36% (6-β) yield. Cmpd 6-α: 1H
NMR (400 MHz, CDCl3) δ 1.99, 2.05, 2.16 (3s, 9H, CH3CO),
2.47 (t, 3J 2.4 Hz, 1H, H-13), 3.67–3.74 (m, 3H, H-9, H-10),
3.83–3.90 (m, 1H, H-9), 4.01 (d, 3J 3.2 Hz, 2H, H-7), 4.11 (m,
2H, H-6), 4.19 (d, 3J 2.4 Hz, 1H, H-11), 4.28 (t, 3JH5–H6 6.6 Hz,
1H, H-5), 4.57 (ddd, 3JH2–H3 11.2 Hz,
3JH2–NH 9.7 Hz,
3JH2–H1 3.7
Hz, 1H, H-2), 4.95 (d, 3JH1–H2 3.7 Hz, 1H, H-1), 5.24 (dd,
3JH3–H2
11.3 Hz, 3JH3–H4 3.3 Hz, 1H, H-3), 5.41 (dd,
3JH4–H3 3.2 Hz,
3JH4–H5 1.2 Hz, 1H, H-4), 6.71 (d,
3JNH–H2 9.7 Hz, 1H, NH).
13C
NMR (100 MHz, CDCl3) δ 20.9 (3 × CH3CO), 42.6 (C-7), 48.3
(C-2), 58.5 (C-11), 62.0 (C-6), 67.0 (C-5), 67.5 (C-4), 67.7 (C-9),
68.6 (C-3), 68.6 (C-10), 75.1 (C-13), 79.5 (C-12), 97.9 (C-1), 166.4
(C-8), 170.4, 170.6, 170.8 (3C, CH3CO). LC-MS (m/z) 486.3 [M +
Na+] (calculated 486.1). Cmpd 6-β: 1H NMR (400 MHz, CDCl3) δ
2.01, 2.05, 2.15 (3s, 9H, CH3CO), 2.45 (t,
3J 2.3 Hz, 1H, H-13),
3.65–3.73 (m, 2H, H-10), 3.76–3.84 (m, 1H, H-9), 3.93 (t, 3J 6.7
Hz, 1H, H-5), 3.97–4.08 (m, 4H, H-2, H-9, H-7), 4.12–4.23 (m,
4H, H-6, H-11), 4.84 (d, 3JH1–H2 8.4 Hz, 1H, H-1), 5.30 (dd,
3JH3–H2 11.3 Hz,
3JH3–H4 3.4 Hz, 1H, H-3), 5.38 (d,
3JH4–H3 3.4
Hz, 1H, H-4), 6.49 (d, 3JNH–H2 8.6 Hz, 1H, NH).
13C NMR
(100 MHz, CDCl3) δ 20.8, 20.8, 20.8 (3C, CH3CO), 42.7 (C-7),
52.1 (C-2), 58.6 (C-11), 61.6 (C-6), 66.8 (C-4), 68.9 (C-9), 69.3
(C-10), 69.8 (C-3), 71.0 (C-5), 74.9 (C-13), 79.6 (C-12), 101.2
(C-1), 166.6 (C-8), 170.3, 170.5, 170.6 (3C, CH3CO). LC-MS (m/z)
486.3 [M + Na+] (calculated 486.1).
Compounds 7-α and 7-β. Under stirring, 6-α or 6-β
(0.16 mmol) and 10 (1 equiv.) were dissolved in THF (1 mL). A
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solution of sodium ascorbate (2 equiv.) and copper sulfate
pentahydrate (1.2 equiv.) in H2O (110 μL) was added, followed
by DIPEA (5 equiv.). The reaction was covered with aluminium
foil and stirred at room temperature for 3 h. The reaction was
extracted with EtOAc (15 mL). The organic extract was washed
with H2O (5 mL) and brine (5 mL), and concentrated under
vacuum. The crude residue was purified by normal phase
column chromatography twice (first solvent system: 50–100%
EtOAc in hexane. Second solvent system: 0–70% acetone in
toluene) to give the title compounds as powders in 74% (7-α)
and 82% (7-β) yield. Cmpd 7-α: 1H NMR (400 MHz, CDCl3) δ
1.98, 2.00, 2.11 (3s, 9H, CH3CO), 2.89 (s, 6H), 3.37–3.43 (m,
2H), 3.70–3.76 (m, 3H), 3.80–3.88 (m, 1H), 3.98 (s, 2H, H-7),
4.03–4.15 (m, 2H, H-6 sugar), 4.29 (td, 3JH5–H6 6.4 Hz,
3JH5–H4
1.4 Hz 1H, H-5 sugar), 4.39–4.52 (m, 2H), 4.56–4.70 (m, 3H,
H-2 sugar, H-aliphatic), 5.01 (d, 3JH1–H2 3.6 Hz, 1H, H-1 anome-
ric), 5.20 (dd, 3JH3–H2 11.3 Hz,
3JH3–H4 3.3 Hz, 1H, H-3 sugar),
5.43 (dd, 3JH4–H3 3.3 Hz,
3JH4–H5 1.4 Hz, 1H, H-4 sugar), 6.14 (t,
3JNH–H15 5.6 Hz, 1H, NH-sulfonamide), 7.14 (d,
3JNH–H2 9.6 Hz,
1H, NH-amide), 7.18 (d, 3J 7.4 Hz, 1H), 7.50–7.57 (m, 2H), 7.61
(s, 1H, H-triazole), 8.19–8.26 (m, 2H), 8.56 (d, 3J 8.5 Hz, 1H).
13C NMR (100 MHz, CDCl3) δ 20.8, 20.9, 21 (3C, CH3CO), 42.7
(C-7), 42.8, 45.6 (×2), 48.3 (C-2 sugar), 50.4, 62.0 (C-6 sugar),
64.4, 66.9 (C-5 sugar), 67.6, 67.6 (C-4 sugar), 68.7 (C-3 sugar),
69.3, 98.0 (C-1 sugar), 115.5, 118.9, 123.3, 124.2 (C-triazole),
128.6, 129.6, 129.6, 130.1, 130.8, 134.7, 144.8 (C-triazole),
152.2, 166.9 (C-amide), 170.6, 170.7, 171.3 (3C, CH3CO).
LC-MS (m/z) 784.3 [M + H+] (calculated 784.2). Cmpd 7-β: 1H
NMR (400 MHz, CDCl3) δ 1.97, 1.99, 2.14 (3s, 9H, CH3CO),
2.89 (s, 6H), 3.33–3.50 (m, 2H), 3.67–3.81 (m, 2H), 3.84–3.99
(m, 3H, H-5 sugar, H-aliphatic), 4.02 (d, 3J 6.9 Hz, 2H, H-7),
4.05–4.20 (m, 3H, H-2, H-6 sugar), 4.40–4.49 (m, 1H), 4.50–4.59
(m, 1H), 4.63 (s, 2H), 4.89 (d, 3JH1–H2 8.5 Hz, 1H, H-1 anome-
ric), 5.21 (dd, 3JH3–H2 11.2 Hz,
3JH3–H4 3.4 Hz, 1H, H-3 sugar),
5.36 (d, 3J 2.9 Hz, 1H, H-4 sugar), 6.07 (t, 3JNH–H15 5.8 Hz, 1H,
NH-sulfonamide), 7.09 (d, 3JNH–H2 8.8 Hz, 1H, NH-amide), 7.19
(d, 3J 7.6 Hz, 1H), 7.61–7.50 (m, 2H), 7.67 (s, 1H, H-triazole),
8.19 (d, 3J 8.7 Hz, 1H), 8.24 (dd, 3J 7.3 Hz, 1.1 Hz, 1H), 8.56 (d,
3J 8.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 20.8, 20.8, 20.9
(3C, CH3CO), 42.8 (C-7), 45.6 (×2), 50.4, 51.8 (C-2 sugar), 61.6
(C-6 sugar), 64.5, 67.0 (C-4 sugar), 68.6, 70.4 (C-3 sugar), 70.7,
70.8 (C-5 sugar), 101.3 (C-1 sugar), 115.6, 118.8, 123.6, 124.6
(C-triazole), 128.8, 129.6, 129.7, 130.2, 131.0, 134.3, 144.8
(C-triazole), 152.2, 167.3 (C-amide), 170.5, 170.6, 170.8 (3C,
CH3CO). LC-MS (m/z) 784.3 [M + H
+] (calculated 784.2).
Compound 9. A solution of dansyl chloride 11 (5.00 mmol),
2-bromoethylamine hydrobromide (1 equiv.) and triethylamine
(2 equiv.) in DCM (25 mL) was stirred at room temperature for
4 h. The solvent was removed under vacuum. The resulting
residue was dissolved in MeCN (50 mL). NaN3 (2.5 equiv.) was
added, and the reaction was stirred at reflux overnight. The
solvent was removed under vacuum, and the crude product
was purified by flash column chromatography (solvent system:
0–50% EtOAc in Hexane) to give 9 as an oil in 87% yield. 1H
NMR (400 MHz, CDCl3) δ 2.89 (s, 6H), 3.03–3.08 (m, 2H),
3.29–3.33 (m, 2H), 4.99 (t, 3J 5.9 Hz, 1H, NH), 7.21 (d, 3J 7.6
Hz, 1H), 7.53 (dd, 3J 8.5 Hz, 3J 7.4 Hz, 1H), 7.60 (dd, 3J 8.6 Hz,
3J 7.7 Hz, 1H), 8.24–8.26 (m, 2H), 8.26–8.28 (m, 2H), 8.57 (d, 3J
8.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 42.5, 45.6, 45.6,
51.1, 115.5, 118.6, 123.3, 128.8, 129.6, 129.8, 130.1, 131.0,
134.6, 152.3. HR-MS (m/z) 320.1182 [M + H]+ (calculated
320.1181).
Compound 10. The title compound was obtained as pre-
viously described28 from 9 and 1-pentyne, under the cyclo-
addition reaction conditions described for 7, in 87% yield. 1H
NMR (400 MHz, CDCl3) 0.95 (t,
3J 7.4 Hz, 3H), 1.58–1.68 (m,
2H), 2.58–2.63 (m, 2H), 2.86 (s, 6H), 3.44 (dd, 3J 11.2 Hz, 3J 6.1
Hz, 2H), 4.30–4.36 (m, 2H), 4.41–4.48 (m, 1H, NH), 7.11 (s, 1H,
H-triazole), 7.19 (d, 3J 7.1 Hz, 1H), 7.51–7.57 (m, 2H), 8.18 (dt,
3J 8.7 Hz, 3J 1 Hz, 1H) 8.25 (dd, 3J 7.3 Hz, 3J 1.2 Hz, 1H),
8.54–8.58 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 14.0, 22.8,
27.7, 42.9, 45.6 (×2), 50.0, 115.5, 118.6, 122.1 (C-triazole),
123.3, 128.9, 129.6, 129.7, 130.1, 131.0, 134.5, 148.3, 152.2.
Biology
Expression of LgtC. Recombinant LgtC was expressed as pre-
viously described37 from E. coli clone NMC-41, transformed
with plasmid containing sequences encoding His-tagged LgtC
and ampicillin resistance.38
Bacterial culture. H. influenzae R2866 was streaked onto
bacitracin chocolate agar plates (Oxoid) from glycerol stock
and incubated at 37 °C. A single colony from the resultant
plate was used to inoculate 10 mL sBHI broth (Oxoid Brain
Heart Infusion broth supplemented with 10 µm mL−1 NAD,
and 10 µL mL−1 Hemin), followed by incubation at 37 °C, 180
rpm overnight. For downstream experiments, fresh sBHI was
then inoculated 1 : 33 to an OD590 of 0.1 and incubated aerobi-
cally at 37 °C and 180 rpm. For growth curves, OD590 was
recorded at various time points in triplicate cultures.
Cell viability. To assess the effect of probes and DMSO
solvent on cell viability, bacterial growth assays were per-
formed by observation of growth on bacitracin chocolate agar
plates. After incubation of cultures with the respective probe
for 2 h in sBHI at 30 °C, 50 μL of culture were plated on baci-
tracin chocolate agar plates and incubated at 37 °C for
48 hours. Viability was assessed by comparative plate count
between cultures incubated with and without probe in DMSO.
Labelling experiments
Materials. NuPAGE™ 4–12% bis–tris protein gels, 1.0 mm,
12-well. PageRuler™ prestained protein ladder 15–190 kDa.
NuPAGE™ MES SDS running buffer (20×).
Protein labelling in intact cells. Cell cultures of H. influenzae
R2866 were grown as described. Upon reaching mid log phase
(OD590 0.9), 4 mL cell cultures were centrifuged at 13 000g for
1 minute. The supernatant was discarded. Cell pellets were
resuspended in PBS (900 μL), and stock solutions of probe or
fluorophore control (100 μL, 10× desired concentration in
DMSO), or DMSO (100 μL, control) were added. Samples were
incubated for 2 hours at 30 °C with regular mixing, and centri-
fuged (2 min, 13 000g). Cell pellets were separated from the
supernatant, washed with a solution of 5% DMSO in PBS, and
centrifuged. This procedure was repeated four times to remove
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unbound fluorophore. After each cycle, the fluorescence of
pellets and washes was examined at 365 nm (Fig. 4).
BugBuster protein extraction reagent (Millipore, 1× in PBB,
100 μL) was added to the cell pellets. Samples were incubated
for 30 min at rt with shaking, and centrifuged (10 min,
13 000g). Supernatant and cell debris were separated, and the
fluorescence of both was examined at 365 nm. Supernatant
(10 μL) from each sample was incubated with loading buffer
(no dye, 2.5 μL) for 10 min at 50 °C. Samples (10 μL) were
loaded on precast SDS-page gels (NuPAGE™ 4 to 12%, bis–tris,
1.0 mm, Novex). Gels were run in 1× MES running buffer at
150 V for 70 min and analysed by fluorescence emission and
Coomassie staining.
Protein labelling in cell lysates. Cell cultures of H. influenzae
R2866 were grown as described above. Cell pellets were iso-
lated by centrifugation and lysed with BugBuster protein
extraction reagent as described. Following centrifugation, the
supernatant from each sample was kept on ice, and the cell
debris was discarded. The supernatants (9 μL) were incubated
with stock solutions of probe or fluorophore control (1 μL, 10×
desired concentration in DMSO), or DMSO (1 μL, control) for
1 hour at 30 °C with regular mixing. Samples (10 μL) were incu-
bated with loading buffer (2.5 μL) for 10 min at 50 °C and ana-
lysed by SDS-page as described.
Protein mass spectrometry
Enzymatic digestion. In-gel reduction, alkylation and diges-
tion with trypsin was performed on selected gel bands prior to
subsequent analysis by mass spectrometry. Cysteine residues
were reduced with dithiothreitol and derivatised by treatment
with iodoacetamide to form stable carbamidomethyl deriva-
tives. Trypsin digestion was carried out overnight at room
temperature after initial incubation at 37 °C for 2 hours.
LC-MS/MS. Peptides were extracted from the gel pieces by a
series of acetonitrile and aqueous washes. The extract was
pooled with the initial supernatant and lyophilised. The
sample was then resuspended in 40 μl of resuspension buffer
(2% ACN in 0.05% FA) and analysed by LC-MS/MS (10 μl).
Chromatographic separation was performed using a U3000
UHPLC NanoLC system (ThermoFisherScientific, UK).
Peptides were resolved by reversed phase chromatography on a
75 μm C18 Pepmap column (50 cm length) using a three-step
linear gradient of 80% acetonitrile in 0.1% formic acid. The
gradient was delivered to elute the peptides at a flow rate of
250 nl min−1 over 60 min starting at 5% B (0–5 minutes) and
increasing solvent to 40% B (5–40 minutes) prior to a wash
step at 99% B (40–45 minutes) followed by an equilibration
step at 5% B (45–60 minutes). The eluate was ionised by elec-
trospray ionisation using an Orbitrap Fusion Lumos
(ThermoFisherScientific, UK) operating under Xcalibur v4.1.5.
The instrument was first programmed to acquire using an
Orbitrap-Ion Trap method by defining a 3 s cycle time between
a full MS scan and MS/MS fragmentation. Orbitrap spectra
(FTMS1) were collected at a resolution of 120 000 over a scan
range of m/z 375–1500 with an automatic gain control (AGC)
setting of 4.0 × 105 with a maximum injection time of 35 ms.
Monoisotopic precursor ions were filtered using charge state
(+2 to +7) with an intensity threshold set between 5.0 × 103 to
1.0 × 1020 and a dynamic exclusion window of 35 s ± 10 ppm.
MS2 precursor ions were isolated in the quadrupole set to a
mass width filter of 1.6 m/z. Ion trap fragmentation spectra
(ITMS2) were collected with an AGC target setting of 1.0 × 104
with a maximum injection time of 35 ms with CID collision
energy set at 35%. This method takes advantage of multiple
analyzers in the Orbitrap Fusion Lumos and drives the system
to use all available parallelizable time, resulting in decreasing
dependence on method parameters.
Database searching. Raw mass spectrometry data were pro-
cessed into peak list files using Proteome Discoverer
(ThermoScientific; v2.2). The raw data file was processed and
searched using the Sequest search algorithm39 against the
current Haemophilus influenzae database from Uniprot (HI;
4957 reviewed entries).
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